Phase 0 pharmacodynamic study of mycophenolate mofetil in patients with pancreatic cancer [Estudio farmacodinamico Fase "0" de Micofenolato Mofetil (MMF, CellCept) en pacientes con cancer de pancreas]
Latest Information Update: 25 Mar 2013
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Pancreatic cancer
- Focus Biomarker; Pharmacodynamics
- Acronyms PROYECTO-FIS
Most Recent Events
- 30 Aug 2011 New trial record